e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction
G. Becher, A. Hillmann, R. Purkhart, M. Graupner, R. Graupner (Bernau, Geyer, Altenburg, Germany)
Source:
Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Session:
Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Session type:
Thematic Poster Session
Number:
4041
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Becher, A. Hillmann, R. Purkhart, M. Graupner, R. Graupner (Bernau, Geyer, Altenburg, Germany). Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction. Eur Respir J 2011; 38: Suppl. 55, 4041
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Clusters of biomarkers in exhaled breath detected by differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
Differential ion mobility spectrometry for detection of metabolites in exhaled breath in airway diseases
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Differentialion mobility spectrometry (DMS) for discrimination of local gut infection in exhaled breath
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Differential ion mobility spectrometry (DMS) for use in non invasive diagnostic from exhaled air
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Detection of pregnancy in horses by breath analysis using differential ion mobility spectrometry (DMS)
Source: Annual Congress 2011 - Lung function today and tomorrow I
Year: 2011
Exhaled breath analysis by ion mobility spectrometry in children with asthma and cystic fibrosis
Source: International Congress 2018 – Cystic fibrosis in paediatric patients: current research
Year: 2018
Ion mobility spectrometry in medical diagnostics: proof of inflammation markers in different parliamentary groups of the exhaled breath
Source: Annual Congress 2008 - Assessment of the respiratory system
Year: 2008
Phenotyping of patients with COPD from exhaled air by ion mobility spectrometry
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012
Detection of infectious agents in the airways by ion mobility spectrometry in exhaled breath
Source: Annual Congress 2010 - Mechanisms of respiratory infections
Year: 2010
Discrimination of protein and peptide composition of exhaled breath condensate in patients with pulmonary disease by mass spectrometry
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
Breath analysis by ion mobility spectrometry allows to discriminate COPD from lung cancer patients.
Source: International Congress 2018 – Lung cancer: from early diagnosis to modern monitoring strategies
Year: 2018
How to measure exhaled breath MDA in normal subjects: assessment of two ionisation modes used by LC-MS/MS.
Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement
Year: 2008
Detection of pseudomonas aeruginosa (
Pa
) specific peaks by ion mobility spectrometry (IMS) in exhaled breath of bronchiectasis patients
Source: Annual Congress 2011 - Role of the biomarkers in airway diseases
Year: 2011
LATE-BREAKING ABSTRACT: Exploiting the ability of 1H-NMR to differentiate patients with severe alpha-1-antitrypsin deficiency from controls based on metabolome profiling of exhaled breath condensate
Source: International Congress 2016 – Late-breaking topics in airways disease
Year: 2016
Determination of volatile organic compounds in exhaled breath of patients with chronic obstructive pulmonary disease by gas chromatography mass spectrometry
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010
Detection of differences in volatile organic compounds (VOCs) by ion mobility spectrometry (IMS) of exhaled breath in patients with interstitial lung diseases (ILDs) compared to healthy controls (HC)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Breath analysis by ion mobility spectrometry in COPD and lung cancer patients
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009
Investigating the reproducibility of real time breath measurements using proton transfer reaction - time of flight - mass spectrometry for breath of volatile organic compounds in COPD Patients.
Source: International Congress 2018 – Biomarkers in COPD and asthma
Year: 2018
The application of mass spectrometry to the analysis and characterization of protein and peptide composition in exhaled breath condensate of pneumo-oncological diseased persons
Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers
Year: 2011
SELDI-TOF MS for proteomic analysis of exhaled breath condensate from patients with pulmonary emphysema
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept